New late-breaking data presented today at ASN Kidney Week 2026 QUELIMMUNE (SCD-PED) treatment group demonstrates statistically significant higher survival in the primary analysis at Day 60, Day 90, ...
Search for a particular organ and a list of the highest-to-lowest-volume centers pops up, with dials to show how they perform ...
The Investor Relations website contains information about Ionis Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
A 16-month pilot demonstrated that a privacy-separated web registry can capture transfusion decisions at the point of care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results